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Objective: To examine levels of C reactive protein in users of
anabolic androgenic steroids (AAS) compared with age
matched control groups consisting of AAS using (but
abstinent)/resistance trained and non-drug using/sedentary
controls.
Method: Subjects included AAS using bodybuilders (n =
10); bodybuilders who denied AAS use (n = 10); sedentary
controls (n = 8). Venous blood was sampled, from which
serum concentrations of C reactive protein, male sex
hormones, and cardiac troponin T were determined.
Results: A significantly altered hormonal profile in the AAS
using group provided indirect confirmation of AAS use. C
reactive protein concentrations were significantly (p,0.05)
higher in the AAS using bodybuilders. There was no relation
between C reactive protein and cardiac troponin T.
Conclusion: AAS using bodybuilders had significantly higher
C reactive protein concentrations, indicating a greater
propensity to develop peripheral arterial disease.
T
hree decades of research have outlined serious conse-
quences of anabolic androgenic steroid (AAS) use on the
haemostatic system.1–3 Recent work has shown raised
levels of C reactive protein (CRP) to be a strong predictor of
cardiovascular events.4 CRP concentrations have not been
studied in AAS users to date.
MATERIALS AND METHODS
Ethical approval for the study was granted by the Bro Taf
local health authority. Subjects were divided into three
groups: AAS users who were still using AAS at time of testing
(n = 10); bodybuilding controls who did not use any
pharmacological ergogenic aids (n = 10); sedentary male
controls (n = 8). Venous blood was sampled using the
standard venepuncture method, from an antecubital vein
after an overnight fast and 30 minutes supine rest5 between
10 00 am and 11 00 am. Morning blood samples were taken
because of the daytime biological variation in testosterone
and sex hormone binding globulin.6 CRP concentrations were
determined using an immunoluminometric assay on a Roche
Integra analyser (Roche Diagnostics, UK).
Data were analysed using the SPSS 10.0 for Windows
statistical package. Group differences were analysed using a
one way analysis of variance followed by a post hoc Tukey
test. Statistical significance was accepted at the p,0.05 level.
RESULTS
Testosterone was significantly (p,0.05) higher in the AAS
using group than controls. Sex hormone binding globulin
was significantly (p,0.01) lower in the AAS users than the
controls. The hormonal profile in the AAS using group is
consistent with the use of exogenous androgens and thus
provided indirect confirmation of AAS use. CRP was
significantly (p,0.05) higher in the AAS using bodybuilders
than the controls (table 1).
DISCUSSION
The mechanism for AAS induced CRP alterations is not
known. An absence of a concurrent increase in troponin T in
the AAS using group indicates inflammation at a source other
than the myocardium. CRP is secreted by hepatocytes in
response to in vivo inflammatory events. Indeed, much
biological activity of AAS also centres around the liver. This
possible link certainly warrants more detailed investigation.
This study adds to the list of potentially prothrombotic
consequences1–3 of non-therapeutic AAS use, and provides a
contraindication to such use.
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Table 1 Male sex hormone data, C reactive protein
(CRP), and troponin T concentrations for anabolic
androgen steroid (AAS) users compared with
bodybuilding and sedentary controls
Variable
AAS users
(n = 10)
Bodybuilding
controls (n = 10)
Sedentary controls
(n = 8)
Testosterone
(nmol/l)
41 (26.1)* 17 (3.7) 15 (3.00
SHBG (nmol/l) 4.0 (2.8)** 13 (8.4) 21 (11.1)
Free androgen
index
10.3*** 1.3 0.7
CRP (mmol/l) 1.2 (0.5)* 0.7 (0.3) 0.5 (0.2)
Troponin T
(mmol/l)
,0.1 ,0.1 ,0.1
Values are mean (SD).
*p,0.05; **p,0.01; ***p,0.001 compared with both controls.
SHBG, Sex hormone binding globulin.
Take home message
Higher levels of C reactive protein in anabolic androgenic
steroid using bodybuilders indicate a greater propensity to
develop future thromboembolytic events.
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